Company News
Company News
Industry Insights

Home > News > Company News > AI-Driven Strain Engineering: Wecare Shortens LBPs & Functional Probiotics R&D Cycles

AI-Driven Strain Engineering: Wecare Shortens LBPs & Functional Probiotics R&D Cycles

June 30 2026

Introduction

Traditional strain engineering relies on random mutation and manual screening, requiring 1–3 years to obtain industrial-adapted strains, restricting the commercialization speed of microbiome therapeutics (TechCrunch, 2026, https://techcrunch.com). Wecare’s proprietary AI microbial development platform realizes predictive strain modification, completely reshaping microbial R&D logic.

Main Body

TechCrunch’s March 2026 report on European biotech startup baCta verified that AI genome simulation technology can optimize microbial metabolic pathways in silico before laboratory tests, cutting trial costs by 60% (TechCrunch, 2026, https://techcrunch.com). Wecare integrates big data of 80,000 sequenced strains into its self-developed AI model, realizing automated dereplication, metabolic pathway simulation and gastrointestinal tolerance prediction. Cooperated with CAE Academician Huang He, the R&D team applied AI engineering to optimize oral LBP strains. Modified strains improve gastric acid and bile salt tolerance by 4.2 times, with in-vivo intestinal colonization rate rising from 18% to 57%. For a Canadian oral care brand, Wecare used AI to screen anti-halitosis Streptococcus strains, finishing product development within 3 months, far faster than the industry average 10-month cycle. Nature Medicine (2026) emphasized that AI strain engineering will become the standard process for industrial mass production of live biotherapeutics, solving the bottleneck of low strain survival rate in oral solid preparations (Nature Medicine, 2026, https://www.nature.com/nm).

Conclusion

AI predictive strain engineering eliminates the blindness of traditional microbial random screening, drastically shortening the R&D cycle of food probiotics, agricultural microbial agents and pharmaceutical LBPs. Supported by multi-academician technical teams, Wecare’s AI platform provides high-efficiency customized strain development services for global industrial clients.


No.999,Guangming Rd., Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province, China
Online Message
Leave a Message